鲁抗医药：拟与关联方续签3年商标使用许可协议

Group 1 - The company plans to renew the trademark licensing agreement with its controlling shareholder, Hualu Group, which constitutes a related party transaction [1] - The transaction has been approved by the company's board of directors and does not require shareholder approval, as it does not constitute a major asset restructuring [1] - The annual fee for the trademark usage is set at 13.45 million yuan, with a validity period from 2026 to 2028 [1] Group 2 - In the past 12 months, the company has engaged in related party transactions with Hualu Group amounting to 7.6 million yuan (including tax) [1] - Hualu Group holds a direct and indirect stake of 23.82% in the company [1]